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Data on biliary carriage of bacteria and, specifically, of bacteria with worrisome and unexpected resistance traits (URB) are lack-
ing. A prospective study (April 2010 to December 2011) was performed that included all patients admitted for<48 h for elective
laparoscopic cholecystectomy in a Spanish hospital. Bile samples were cultured and epidemiological/clinical data recorded. Lo-
gistic regressionmodels (stepwise) were performed using bactobilia or bactobilia by URB as dependent variables. Models (P<
0.001) showing the highest R2 values were considered. A total of 198 patients (40.4%males; age, 55.3 17.3 years) were included.
Bactobilia was found in 44 of them (22.2%). The presence of bactobilia was associated (R2 Cox, 0.30) with previous biliary endo-
scopic retrograde cholangiopancreatography (ERCP) (odds ratio [OR], 8.95; 95% confidence interval [CI], 2.96 to 27.06; P<
0.001), previous admission (OR, 2.82; 95% CI, 1.10 to 7.24; P 0.031), and age (OR, 1.09 per year; 95% CI, 1.05 to 1.12; P<
0.001). Ten out of the 44 (22.7%) patients with bactobilia carried URB: 1 Escherichia coli isolate (CTX-M), 1 Klebsiella pneu-
moniae isolate (OXA-48), 3 high-level gentamicin-resistant enterococci, 1 vancomycin-resistant Enterococcus isolate, 3 Entero-
bacter cloacae strains, and 1 imipenem-resistant Pseudomonas aeruginosa strain. Bactobilia by URB (versus those by non-URB)
was only associated (R2 Cox, 0.19) with previous ERCP (OR, 11.11; 95% CI, 1.98 to 62.47; P 0.006). For analyses of patients
with bactobilia by URB versus the remaining patients, previous ERCP (OR, 35.284; 95% CI, 5.320 to 234.016; P< 0.001), previ-
ous intake of antibiotics (OR, 7.200; 95% CI, 0.962 to 53.906; P 0.050), and age (OR, 1.113 per year of age; 95% CI, 1.028 to
1.206; P 0.009) were associated with bactobilia by URB (R2 Cox, 0.19; P< 0.001). Previous antibiotic exposure (in addition to
age and previous ERCP) was a risk driver for bactobilia by URB. This may have implications in prophylactic/therapeutic
measures.
Bacteria may invade the biliary tract by ascending from theduodenum and by a hematogenous route from the hepatic
portal vein. Bactobilia are not found in healthy individuals, since
daily excretion of bile helps to flush out whatever organisms enter
the biliary tract, but the percentage of bactobilia increases to 3% in
patients with gallstones and to 30% in patients with common
duct stones (1, 2).
About 15% of patients with gallstones are subjected to surgery
for uncomplicated symptomatic gallstones (3). The presence of
bacteria has been reported in 20 to 40% of patients with symp-
tomatic gallstones but no evidence of cholecystitis (1, 4, 5). There
are conflicting reports on the association of positive bile cultures
with surgical infections and septic complications (1, 6–9). Post-
operative wound infection after elective cholecystectomy ranges
from 7 to 20% (6, 10, 11), and the potential benefit of antibiotics is
not to eradicate organisms but to control extraluminal extension
of infection (12) and to prevent surgical complications. Identifi-
cation of risk factors for bactobilia and bile cultures during biliary
surgery are useful for planning antibiotic prophylaxis and treat-
ment measures (6, 9, 13). However, a recent systematic review of
the Cochrane database showed that there is not sufficient evidence
to support or refute the use of antibiotic prophylaxis to reduce
surgical site infection and global infections in patients undergoing
elective laparoscopic cholecystectomy with low risk of anesthetic
complications, comorbidities, conversion to open surgery, and
infectious complications (14).
The most common isolate from bile at cholecystectomy from
patients with uncomplicated cholelithiasis is Escherichia coli, fol-
lowed by Klebsiella spp. and Enterococcus spp. (6, 11). Although
there is an increasing number of reports of worrisome resistance
traits (extended-spectrum -lactamase [ESBL] or AmpC produc-
tion, vancomycin resistance, methicillin resistance, etc.) for iso-
lates from community-acquired infections (15–19), this has not
been reported for biliary isolates from asymptomatic patients with
gallstones.
This study aims to explore bile carriage of bacteria with worri-
some andunexpected resistance traits and to determine associated
risk factors in patients admitted to hospital for48 h for elective
laparoscopic cholecystectomy.
(Part of this study was presented at the 52nd Interscience Con-
ference on Antimicrobial Agents and Chemotherapy, 9 to 12 Sep-
tember 2012, San Francisco, CA [20].)
MATERIALS AND METHODS
A prospective, observational study was carried out from April 2010 to
December 2011 in all patients who were 14 years of age and had been
admitted for48 h in Hospital Universitario La Paz (Madrid, Spain) for
elective laparoscopic cholecystectomy. A single perioperative dose of
amoxicillin-clavulanic acid or cefazolin was used as prophylaxis accord-
ing to the hospital’s routine. Patients hospitalized for 48 h and those
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with symptomatic cholecystitis or choleangitis were excluded. The study
protocol was approved by the Ethical Review Board of Hospital La Paz
(registration no. HULP: PI-1021), and patients signed a written informed
consent prior to study inclusion.
Demographic and clinical data were recorded from clinical records,
and the age-unadjusted Charlson index (21) (age was considered sepa-
rately) and the modified McCabe score (Sabadell score) (22) were calcu-
lated. Antibiotic intake in the previous 2months or in the previous year (if
more than two antibiotic courses), hospitalizations in the previous 12
months, intake of steroids, history of recurrent urinary tract infections,
and the intake of proton pump inhibitors or other antacids within the
previous 2 months were recorded. Surgery, biliary endoscopic retrograde
cholangiopancreatography (ERCP), or other endoscopic or invasive pro-
cedures within the previous 12 months were also recorded.
Bile samples were collected during cholecystectomy and immediately
sent to the Microbiology Department for aerobic and anaerobic culture.
Identification was performed using Wider (Soria Melguizo S.A., Madrid,
Spain) and/or matrix-assisted laser desorption ionization–time-of-flight
(MALDI-TOF; Bruker Daltonics, Inc., Billerica, MA) systems. Antibiotic
susceptibility was determined using theWider automated system accord-
ing to CLSI guidelines (23). ESBLs and carbapenemases were phenotypi-
cally confirmed (Etest ESBL andmodifiedHodge test, respectively). PCRs
with specific primers were used for the detection of carbapenemase genes
(KPC, VIM, IMP, NDM-1, and OXA-48) and ESBL genes (TEM, SHV,
CTX-M, and OXA-1) (24). Vancomycin-resistant or high-level gentami-
cin-resistant Enterococcus spp., methicillin-resistant Staphylococcus au-
reus, Pseudomonas aeruginosa, and Acinetobacter baumannii, or ESBL- or
AmpC-producing enterobacteria were considered bacteria with worri-
some and unexpected resistance traits in the community (unexpected
resistant bacteria, or URB).
Comparison of proportions was performed by chi-square test and
Fisher’s exact test when necessary. For quantitative variables, since data
did not show normality in the Kolmogorov-Smirnoff test, the Kruskal-
Wallis andMann-Whitney tests were used when necessary. Bivariate ana-
lyses were performed to compare all variables between patients with pos-
itive culture to those of patients with negative cultures, between patients
with URB bactobilia and patients with non-URB bactobilia, and between
patients with URB bactobilia and the remaining patients (patients with
negative culture plus those with non-URB-positive cultures). Logistic re-
gressionmodels (stepwise procedure) were performed using bactobilia or
URB bactobilia as dependent variables and those showing differences
(P 0.1) in bivariate analyses as independent variables. Interactions and
linear dependence between independent variables were previously con-
trolled. The statistical analysis was performed using SPSS, version 4 (SPSS
Inc., Chicago, IL). The models showing the highest R2 values were con-
sidered.
RESULTS
A total of 198 patients were included; 44 (22.2%) of them had
positive bile cultures. All positive cultures yielded growth of fac-
ultative microorganisms, with only 4 out of the 44 (9.1%) in
mixed cultures with strict anaerobes (2 patients showing Clostrid-
ium spp., 1 patient showing Bacteroides fragilis, and 1 patient
showing B. fragilis and Clostridium spp.). The most frequently
isolated facultative microorganism was Enterococcus spp., which
was present in 16 out of the 44 (36.7%) patients with bactobilia,
followed by E. coli and Klebsiella spp., present in 13 (29.5%) pa-
tients each. Ten patients presented URB isolates (10/44; 22.7%): 3
patients with Enterobacter cloacae, 2 with ESBL-producing enter-
obacteria (1 CTX-M-producing E. coli and 1 OXA-48-producing
K. pneumoniae), 2 with high-level gentamicin-resistant Enterococ-
cus faecium, 2 with vancomycin-resistantEnterococcus casseliflavus
(with one of them also showing high-level gentamicin-resistant
Enterococcus faecalis), and 1with aP. aeruginosa isolate resistant to
piperacillin-tazobactam, ceftazidime, cefepime, and imipenem.
Table 1 includes variables showing significance in any of the
three bivariate analyses performed. The group of patients with
bactobilia (compared to those with negative culture) had a signif-
icantly (P  0.05) higher mean age and Charlson index. This
group also showed significantly higher percentages ofmales and of
patients with high blood pressure, with previous stroke, with hos-
pitalization in the previous year, with intake of proton-pump in-
hibitors and of previous antibiotics, and with previous ERCP or
other endoscopic procedures than patients without bactobilia. In
the multivariate analysis (R2 Cox, 0.297; P  0.001), previous
ERCP (odds ratio [OR], 8.951; 95% confidence interval [CI],
2.961 to 27.056; P 0.001), previous admission (OR, 2.821; 95%
CI, 1.099 to 7.240; P 0.031), and age (OR, 1.081 per year of age;
95% CI, 1.048 to 1.116; P  0.001) were significantly associated
with bactobilia.
The group of patients with URB bactobilia (compared to those
with non-URB bactobilia) had a significantly (P  0.05) higher
TABLE 1 Variables showing significance in the three bivariate analyses performed
Parameter Total
Result according to patient status
Sterile bile Bactobilia
Non-URB
bactobilia
URB
bactobilia
Sterile bile non-URB
bactobilia
n 198 154 44 34 10 188
Age (yr; means SD) 55.3 17.3 51.2 16.3 69.6 12.5a 67.6 13.0 76.2 8.2b 54.2 17.0c
Male (%) 40.4 36.4 54.4a 55.9 50.0 39.9
High blood pressure (%) 35.8 29.2 59.1a 52.9 80.0 33.5c
Stroke (%) 10.7 7.8 20.5a 20.6 20.0 10.2
Charlson index (means SD) 1.40 0.95 0.82 1.41 1.41 1.28a 1.38 1.23 1.50 1.51 0.93 1.40
Proton pump inhibitors (%) 40.4 34.4 61.4a 58.8 70.0 38.8
Previous antibiotics (%) 33.8 28.6 52.3a 44.1 80.0 31.4c
Previous admission (%) 56.1 48.7 81.8a 79.4 90.0 54.3c
Previous surgery (%) 3.5 2.6 6.8 2.9 20.0 2.7c
ERCP (%) 13.6 6.5 38.6a 26.5 80.0b 10.0c
Other endoscopic procedures (%) 18.7 14.9 31.8a 32.4 30.0 18.1
a P 0.05 for bactobilia versus sterile bile.
b P 0.05 for URB bactobilia versus non-URB bactobilia.
c P 0.05 for sterile bile plus non-URB bactobilia versus URB bactobilia.
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mean age and a higher rate of patients with previous ERCP (Table
1). In the multivariate analysis (R2 Cox, 0.192; P  0.001), only
previous ERCP (OR, 11.110; 95% CI, 1.976 to 62.466; P 0.006)
was associatedwithURBbactobiliawhen the analysiswas adjusted
by age and by previous intake of antibiotics.
In comparisons of the group of patients withURB bactobilia to
grouped patients showing no bactobilia or non-URB bactobilia
(Table 1), significantly (P  0.05) higher mean ages and higher
percentages of patients with high blood pressure, with previous
intake of antibiotics, with previous surgery, with hospitalization
in the previous year, and with previous ERCP were found among
patients withURB bactobilia. In themultivariate analysis (R2 Cox,
0.194; P 0.001), previous ERCP (OR, 35.284; 95% CI, 5.320 to
234.016; P  0.001), previous intake of antibiotics (OR, 7.200;
95% CI, 0.962 to 53.906; P 0.050), and age (OR, 1.113 per year
of age; 95% CI, 1.028 to 1.206; P  0.009) were associated with
URB bactobilia.
DISCUSSION
Some reports have shownhigher incidences of postoperativemor-
bidity and infectious complications in patients with bactobilia
versus those without it (2, 25). It is well known that bactobilia is a
common finding in patients with risk factors, such as biliary ob-
struction, age of70 years, acute cholecystitis, common bile duct
stones, cholangitis, and nonfunctioning gallbladders (13, 26). In
patients undergoing laparoscopic cholecystectomy, a previous
study showed that preoperative ERCP and age were predictors of
bactobilia (7). It has been suggested that prophylactic antibiotics
should be limited to patients with risk factors of bactobilia (13),
but there is not sufficient evidence to support or refute the use of
antibiotic prophylaxis in patients undergoing elective laparo-
scopic cholecystectomy with low risk of complications (14). Since
bactobilia status at the time of surgery, and especially in the pres-
ence of resistant bacteria, is unknown, identification of predictors
of bactobilia by resistant bacteria is important. In this sense, as in
previous publications on intra-abdominal infections (27, 28), the
concept of resistant bacteria that we used in the present study was
wider than the classical definition of multidrug-resistant bacteria
(i.e., acquired resistance to three ormore antimicrobial classes) to
include vancomycin-resistant and high-level gentamicin-resistant
Enterococcus spp.; methicillin-resistant Staphylococcus aureus,
Pseudomonas aeruginosa, and Acinetobacter baumannii; and
ESBL- and AmpC-producing enterobacteria (all of them are con-
sidered URB in bile).
In the present study, bactobilia was found in 22.2% of patients
with elective laparoscopic cholecystectomy, with predictors of
bactobilia being previous ERCP, previous hospital admission, and
age, as described in a previous report (7). More interestingly,
22.7% of those with bactobilia presented URB isolates. This fact
should be considered in the selection of the antibiotic used for
prophylaxis for cholecystectomy in patients with risk factors.
ThreeE. cloacae isolates (thatmust be considered inducible AmpC
chromosomal -lactamase producers [15]), one ESBL-producing
E. coli strain (thus conferring resistance to narrow-, expanded-,
and broad-spectrum cephalosporins and aztreonam [29]), and
one carbapenemase-producing K. pneumoniae strain (conferring
resistance to all current-lactams)were isolated in addition to aP.
aeruginosa isolate that also was resistant to cephalosporins and
carbapenems. With respect to Gram positives, four Enterococcus
spp. (two with vancomycin resistance and two with aminoglyco-
side high-level resistance) were isolated. In enterococci, in addi-
tion to the acquisition of resistance to ampicillin, aminoglycoside
(high-level) and glycopeptide resistance is a cause for concern
(17).
Risk factors identified in the multivariate analysis for the iso-
lation of these URB bacteria were previous ERCP and age, as for
bactobilia, but importantly, they also included previous antibiotic
exposure (OR of 7.200 versus patients with non-URB bactobilia).
Unfortunately, since only 10 URB isolates were identified, no as-
sociation could be found with antibiotic classes previously taken
by these patients. The results of the present study warrant wider
studies to explore the relationship between URB bactobilia and
postsurgery complications.
In conclusion, the prevalence of bactobilia found in the com-
munity of patients undergoing elective laparoscopic cholecystec-
tomy (with nearly one-fourth of patients with bactobilia carrying
URB bacteria) was not negligible. When establishing prophylactic
or therapeuticmeasures in patients presenting risk factors for bac-
tobilia, it should be taken into account that previous antibiotic
exposure is a risk driver for bactobilia by bacteria with worrisome
and unexpected resistance traits.
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